Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Krishna Institute of Medical Sciences EV-to-EBIT?
Krishna Institute of Medical SciencesNSE:KIMS -2.01%88 EV-to-EBIT is 65.42 as of Sep. 01, 2026, which is 106% above its 10-year median of 31.74. GuruFocus rates NSE:KIMS with a GF Score™ of 88/100 and a GF Value™ of ₹869.42 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Krishna Institute of Medical Sciences ranks worse than 90.15% on this metric.
NSE:KIMS's EV-to-EBIT is ranked worse than 90.15% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.67
vs NSE:KIMS: 65.42
Krishna Institute of Medical Sciences (NSE:KIMS) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Krishna Institute of Medical Sciences's Enterprise Value for the quarter that ended in Jun. 2026 was ₹325,953 Mil.
Krishna Institute of Medical Sciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,301 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences EV-to-EBIT Related Terms
Krishna Institute of Medical Sciences EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences EV-to-EBIT Chart
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's EV-to-EBIT falls into.
Krishna Institute of Medical Sciences's current Enterprise Value is ₹346,800 Mil.
Krishna Institute of Medical Sciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,301 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences (NSE:KIMS) has a EV-to-EBIT of 65.42 as of Sep. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Krishna Institute of Medical Sciences and its competitors. This is 106% above median its historical median of 31.74. Over the past decade, Krishna Institute of Medical Sciences' EV-to-EBIT has ranged from 18.97 to 68.52. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #430 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is Krishna Institute of Medical Sciences' EV-to-EBIT too high?
Krishna Institute of Medical Sciences' current EV-to-EBIT of 65.42 is 106% above median its 10-year median of 31.74. Over the past 10 years, this metric has ranged from a low of 18.97 to a high of 68.52. The Healthcare Providers & Services industry median EV-to-EBIT is 15.67. Krishna Institute of Medical Sciences' value of 65.42 is 317.5% above this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #430 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #430 out of 477 companies for EV-to-EBIT. This places Krishna Institute of Medical Sciences in the lower half of its industry. The industry median EV-to-EBIT is 15.67. Krishna Institute of Medical Sciences' value of 65.42 is 317.5% above this benchmark. Historically, Krishna Institute of Medical Sciences' own EV-to-EBIT has ranged from 18.97 to 68.52 over the past decade. While the company's 10-year median is 31.74 vs. the industry median of 15.67, Krishna Institute of Medical Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.67, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current EV-to-EBIT of 65.42 is 317.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current EV-to-EBIT is 65.42, which is 106% above median its own 10-year median of 31.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹869.42, compared to a current price of ₹755.50 — trading 13.1% below its estimated fair value. The current EV-to-EBIT is 65.42, which is 106% above median its 10-year median of 31.74 and 317.5% above the Healthcare Providers & Services industry median of 15.67. Krishna Institute of Medical Sciences' overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current EV-to-EBIT is 65.42 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued.
The current stock price of ₹755.50 is trading 13.1% below its estimated GF Value™ of ₹869.42.
GuruFocus considers Krishna Institute of Medical Sciences to be Modestly Undervalued.
Key valuation signals for NSE:KIMS:
EV-to-EBIT: 65.42 (106% above median its 10-year median of 31.74)
GF Value™: ₹869.42 vs. price of ₹755.50 (13.1% below fair value)
Industry Position: 317.5% above the Healthcare Providers & Services median (#430 of 477)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
88GF Score
Get the complete analysis for NSE:KIMS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
